.On the heels of an FDA denial for its own chief rival Novo Nordisk, Eli Lilly is gaining ground in ...
.Just a few months after application the very first person in a phase 2 test for freshly identified ...
.Eli Lilly's look for excessive weight aim ats has led it to the darker genome. The Big Pharma has a...
.Collection Biosciences is actually going on up. The tissue therapy firm has added $325 thousand in ...
.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...
.Aelis Farma's hopes of getting a fast, beneficial selection on a $one hundred million possibility r...
.ProKidney has ceased some of a set of phase 3 trials for its cell therapy for renal illness after d...
.Vaxcyte revealed what experts called "magnificent" stage 1/2 records for its own 31-valent pneumoco...
.Recursion has stumbled by means of an early exam of its tech-enabled strategy to medicine discovery...
.Phone it a situation of excellent chemistry: Acepodia, a biotech based upon Nobel Prize-winning sci...